Campbell & Co Investment Adviser’s BioNTech BNTX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.79M	Buy	+19,279	New	+$1.81M	0.09%	359
2026 Q1	–	Sell	-46,895	Closed	-$4.46M	–	1092
2025 Q4	$4.46M	Buy	+46,895	New	+$4.72M	0.21%	121
2023 Q4	–	Sell	-2,673	Closed	-$290K	–	1103
2023 Q3	$290K	Buy	2,673 +404	+18%	+$44.7K	0.03%	727
2023 Q2	$245K	Buy	+2,269	New	+$255K	0.04%	737

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Campbell & Co Investment Adviser's BNTX Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in BioNTech (BNTX) in Q2 2026: 19,279 shares worth $1.79M. The stake represents 0.09% of the portfolio and ranks #359 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in BNTX as recently as Q4 2025.

Campbell & Co Investment Adviser first reported a position in BNTX in Q2 2023 and has held it in 4 quarters since. The position peaked at $4.46M in Q4 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Campbell & Co Investment Adviser held 19,279 shares of BioNTech worth $1.79M as of Q2 2026.
BioNTech was a new Campbell & Co Investment Adviser position in Q2 2026.
BioNTech made up 0.09% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #359 holding.
Campbell & Co Investment Adviser first reported a position in BioNTech in Q2 2023 and has held it in 4 quarters since.
Campbell & Co Investment Adviser's BioNTech position peaked at $4.46M in Q4 2025.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.